Toolkit/biosensors

biosensors

Assay Method·Research·Since 2025

Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Biosensors have shown potential for success in diagnostic testing due to their ease of use, inexpensive materials, rapid results, and portable nature. Biosensors can be combined with nanomaterials to produce sensitive and easily interpretable results.

Usefulness & Problems

Why this is useful

Biosensors are listed as emerging technologies included in the review's coverage of efflux detection methods. They are grouped with novel technologies that offer improved precision over classical methods.; efflux detection; molecular detection; Biosensors are presented as rapid diagnostic tools for detecting bacterial resistance, including carbapenem resistance-related targets. The review highlights them as emerging alternatives to slower conventional AMR diagnostics.; rapid diagnostic testing for bacterial resistance; detection of antimicrobial resistance; portable diagnostic assays

Source:

Biosensors are listed as emerging technologies included in the review's coverage of efflux detection methods. They are grouped with novel technologies that offer improved precision over classical methods.

Source:

efflux detection

Source:

molecular detection

Source:

Biosensors are presented as rapid diagnostic tools for detecting bacterial resistance, including carbapenem resistance-related targets. The review highlights them as emerging alternatives to slower conventional AMR diagnostics.

Source:

rapid diagnostic testing for bacterial resistance

Source:

detection of antimicrobial resistance

Source:

portable diagnostic assays

Problem solved

They address limitations of older efflux detection approaches by supporting more precise detection.; providing newer detection technologies with improved precision relative to classical methods; They address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.; need for inexpensive and rapid AMR detection assays

Source:

They address limitations of older efflux detection approaches by supporting more precise detection.

Source:

providing newer detection technologies with improved precision relative to classical methods

Source:

They address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.

Source:

need for inexpensive and rapid AMR detection assays

Problem links

Limited Diagnostic Tools Optimized for Low-Resource Settings

Gap mapView gap

The item summary explicitly highlights ease of use, inexpensive materials, rapid results, and portability, which are core needs for diagnostics in low-resource settings. Biosensor formats could plausibly support simpler frontline detection than centralized lab methods.

We Can’t Yet Replicate Animal Olfaction Synthetically as a Sensing and Classification Modality

Gap mapView gap

Biosensors are generally relevant to the synthetic sensing part of the gap because they provide practical chemical detection formats with rapid and portable readouts. They could support early prototyping of odor-responsive devices, though the supplied evidence is generic rather than olfaction-specific.

need for inexpensive and rapid AMR detection assays

Literature

They address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.

Source:

They address the need for faster, lower-cost, and more portable AMR diagnostic assays than current gold-standard methods. The review frames this as important for effective AMR detection and management.

providing newer detection technologies with improved precision relative to classical methods

Literature

They address limitations of older efflux detection approaches by supporting more precise detection.

Source:

They address limitations of older efflux detection approaches by supporting more precise detection.

Published Workflows

Objective: Use biosensors to improve microbial metabolic engineering and substrate-to-product bioconversion for lignocellulosic biomass conversion.

Why it works: The abstract states that biosensors hold significant potential to advance microbial metabolic engineering and enhance substrate-to-product bioconversion, implying that integrating sensing with pathway engineering can help address optimization bottlenecks.

biosensor-mediated monitoring or control of metabolic pathwaysbiosensor developmentbiosensor optimizationmicrobial metabolic engineering

Taxonomy & Function

Primary hierarchy

Technique Branch

Method: A concrete measurement method used to characterize an engineered system.

Mechanisms

No mechanism tags yet.

Target processes

diagnosticediting

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor

The abstract indicates that biosensors use inexpensive materials and may be combined with nanomaterials. Specific transducers, probes, or sample-preparation requirements are not given in the abstract.; may require integration with nanomaterials for improved sensitivity and interpretability

The abstract does not show that biosensors replace all gold-standard diagnostics or provide comprehensive genomic characterization. It also does not specify performance limits across organisms or sample types.; the abstract does not specify which biosensor formats or targets are most validated

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1method limitationsupports2025Source 2needs review

Classical efflux detection methods such as MIC shifts with inhibitors and fluorometric assays have technical limitations, whereas novel technologies offer improved precision.

Classical methods for detecting efflux (e.g. minimum inhibitory concentration (MIC) shifts with inhibitors, fluorometric assays) have technical limitations, while novel technologies offer improved precision.
Claim 2review summarysupports2025Source 1needs review

Biosensors have potential for diagnostic testing because they are easy to use, use inexpensive materials, provide rapid results, and are portable.

Claim 3review summarysupports2025Source 1needs review

Combining biosensors with nanomaterials can produce sensitive and easily interpretable diagnostic results.

Claim 4review summarysupports2025Source 1needs review

Current methods for detecting antimicrobial resistance genes are expensive and time-consuming.

Claim 5review summarysupports2025Source 1needs review

Polymerase chain reactions and whole-genome sequencing are considered gold-standard diagnostics for antimicrobial resistance detection.

Claim 6review summarysupports2025Source 1needs review

There is a need for inexpensive, rapid diagnostic assays for effective antimicrobial resistance detection and management.

Approval Evidence

2 sources4 linked approval claimsfirst-pass slug biosensors
Biosensors have shown potential for success in diagnostic testing due to their ease of use, inexpensive materials, rapid results, and portable nature. Biosensors can be combined with nanomaterials to produce sensitive and easily interpretable results.

Source:

The review integrates data from in vitro, in silico, and clinical studies, including both classical detection strategies and emerging technologies such as clustered regularly interspaced short palindromic repeats (CRISPR)-based modulation, biosensors, and microfluidics.

Source:

method limitationsupports

Classical efflux detection methods such as MIC shifts with inhibitors and fluorometric assays have technical limitations, whereas novel technologies offer improved precision.

Classical methods for detecting efflux (e.g. minimum inhibitory concentration (MIC) shifts with inhibitors, fluorometric assays) have technical limitations, while novel technologies offer improved precision.

Source:

review summarysupports

Biosensors have potential for diagnostic testing because they are easy to use, use inexpensive materials, provide rapid results, and are portable.

Source:

review summarysupports

Combining biosensors with nanomaterials can produce sensitive and easily interpretable diagnostic results.

Source:

review summarysupports

There is a need for inexpensive, rapid diagnostic assays for effective antimicrobial resistance detection and management.

Source:

Comparisons

Source-stated alternatives

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

Source:

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

Source-backed strengths

novel technologies offer improved precision; ease of use; inexpensive materials; rapid results; portable nature; can yield sensitive and easily interpretable results when combined with nanomaterials

Source:

novel technologies offer improved precision

Source:

ease of use

Source:

inexpensive materials

Source:

rapid results

Source:

portable nature

Source:

can yield sensitive and easily interpretable results when combined with nanomaterials

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

Shared frame: source-stated alternative in extracted literature

Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.

Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.

Source:

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

Shared frame: source-stated alternative in extracted literature

Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.

Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.

Source:

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

Shared frame: source-stated alternative in extracted literature

Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.

Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.

Source:

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

Shared frame: source-stated alternative in extracted literature

Strengths here: novel technologies offer improved precision; ease of use; inexpensive materials.

Relative tradeoffs: the abstract does not specify which biosensor formats or targets are most validated.

Source:

The abstract contrasts biosensors with polymerase chain reactions and whole-genome sequencing, which it describes as gold-standard diagnostics. These alternatives are characterized as expensive and time-consuming.

Ranked Citations

  1. 1.

    Seeded from load plan for claim cl3. Extracted from this source document.

  2. 2.
    StructuralSource 2MED2025Claim 1

    Extracted from this source document.